CU20100137A7 - DERIVATIVES OF 19-NOR-STEROID THAT HAS A GROUP 15, 16-METHYLENE AND A RING OF 17, 17-SATURATED ESPIROLACTONE, ITS USE AND MEDICINES THAT UNDERSTAND - Google Patents

DERIVATIVES OF 19-NOR-STEROID THAT HAS A GROUP 15, 16-METHYLENE AND A RING OF 17, 17-SATURATED ESPIROLACTONE, ITS USE AND MEDICINES THAT UNDERSTAND

Info

Publication number
CU20100137A7
CU20100137A7 CU20100137A CU20100137A CU20100137A7 CU 20100137 A7 CU20100137 A7 CU 20100137A7 CU 20100137 A CU20100137 A CU 20100137A CU 20100137 A CU20100137 A CU 20100137A CU 20100137 A7 CU20100137 A7 CU 20100137A7
Authority
CU
Cuba
Prior art keywords
hydrogen
methylene
group
alkyl
derivatives
Prior art date
Application number
CU20100137A
Other languages
Spanish (es)
Inventor
Hans-Peter Muhn
Thomas Frenzel
Frederik Menges
Steffen Borden
Katja Prelle
Jan Huebner
Sven Ring
Joachim Kuhnke
Rolf Bohlmann
Ulrich Klar
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Priority to CU20100137A priority Critical patent/CU20100137A7/en
Publication of CU20100137A7 publication Critical patent/CU20100137A7/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Los derivados de y-lactona del ácido 15alfa,16alfa-metilen-17-hidroxi-19-nor-17-pregna-4-en-3-ona-21-carboxílico de la presente invención poseen efectividad gestagénica. Tienen la fórmula química general I, en la cual Z se selecciona del grupo que comprende un átomo de oxígeno, dos átomos de hidrógeno, NOR y NNHSO2R, donde R es hidrógeno, alquilo-C1-C10, arilo o aralquilo-C7-C20, R4 es hidrógeno o halógeno; además, R6a, R6b forman juntos metileno o 1,2-etandiilo p R6a es hidrógeno y R6b se selecciona del grupo que comprende hidrógeno, alquilo-C1-C10, alquenilo-C2-C10 o alquinilo-C2-C10, y R7 se selecciona del grupo que comprende hidrógeno, alquilo-C1-C10, cicloalquilo-C3-C6, alquenilo-C2-C10 o alquinilo-C2-C10 o: R6a es hidrógeno y R6b y R7 juntos forman un enlace, un oxígeno o metileno, R18 representa hidrógeno o alquilo-C1-C3 y comprenden además sus solvatos, hidratos, estereoisómeros y sales.The y-lactone derivatives of 15alpha, 16alpha-methylene-17-hydroxy-19-nor-17-pregna-4-en-3-one-21-carboxylic acid of the present invention possess gestagenic effectiveness. They have the general chemical formula I, in which Z is selected from the group comprising an oxygen atom, two hydrogen atoms, NOR and NNHSO2R, where R is hydrogen, C1-C10 alkyl, aryl or aralkyl-C7-C20, R4 is hydrogen or halogen; in addition, R6a, R6b together form methylene or 1,2-ethanediyl p R6a is hydrogen and R6b is selected from the group comprising hydrogen, C1-C10 alkyl, C2-C10 alkenyl or C2-C10 alkynyl, and R7 is selected from the group comprising hydrogen, C1-C10 alkyl, C3-C6 cycloalkyl, C2-C10 alkenyl or C2-C10 alkynyl or: R6a is hydrogen and R6b and R7 together form a bond, an oxygen or methylene, R18 represents hydrogen or C1-C3 alkyl and further comprise its solvates, hydrates, stereoisomers and salts.

CU20100137A 2010-06-29 2010-06-29 DERIVATIVES OF 19-NOR-STEROID THAT HAS A GROUP 15, 16-METHYLENE AND A RING OF 17, 17-SATURATED ESPIROLACTONE, ITS USE AND MEDICINES THAT UNDERSTAND CU20100137A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20100137A CU20100137A7 (en) 2010-06-29 2010-06-29 DERIVATIVES OF 19-NOR-STEROID THAT HAS A GROUP 15, 16-METHYLENE AND A RING OF 17, 17-SATURATED ESPIROLACTONE, ITS USE AND MEDICINES THAT UNDERSTAND

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20100137A CU20100137A7 (en) 2010-06-29 2010-06-29 DERIVATIVES OF 19-NOR-STEROID THAT HAS A GROUP 15, 16-METHYLENE AND A RING OF 17, 17-SATURATED ESPIROLACTONE, ITS USE AND MEDICINES THAT UNDERSTAND

Publications (1)

Publication Number Publication Date
CU20100137A7 true CU20100137A7 (en) 2011-10-31

Family

ID=45000108

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20100137A CU20100137A7 (en) 2010-06-29 2010-06-29 DERIVATIVES OF 19-NOR-STEROID THAT HAS A GROUP 15, 16-METHYLENE AND A RING OF 17, 17-SATURATED ESPIROLACTONE, ITS USE AND MEDICINES THAT UNDERSTAND

Country Status (1)

Country Link
CU (1) CU20100137A7 (en)

Similar Documents

Publication Publication Date Title
CY1124404T1 (en) BILE ACID DERIVATIVES AS FXR/TGR5 AGENTS AND METHODS OF USING THEREOF
CR20170118A (en) SPIRODIAMINE DERIVATIVES AS INHIBITORS OF ALDOSTERONA SINTASA
AR107519A1 (en) PIPERIDINE SUBSTITUTED COMPOUNDS AND THEIR USE
AR100251A1 (en) LISINA SPECIFIC DEMATILASE INHIBITORS-1
CR20150509A (en) USEFUL NAFTIRIDINE DERIVATIVES AS ANTAGONISTS OF THE ALFA-V-BETA-6 INTEGRINE
AR066970A1 (en) DERIVED FROM 17 BETA-CIANO-18A-HOMO-19-NOR-ANDROST-4- ENO, ITS USE AND MEDICATION CONTAINING IT
CO7400872A2 (en) Substituted derivatives of phthalazin-1 (2h) -one
CR20140091A (en) NEW DIHYDROQUINOLINE-2-ONA DERIVATIVES
CR20180072A (en) NEW BICYCLE COMPOUNDS AS ATX INHIBITORS
AR088226A1 (en) HETEROCICLIC PIPERIDINIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
PH12016500895B1 (en) Substituted piperidyl-ethyl-pyrimidine as ghrelin o-acyl transferase inhibitor
RS54730B1 (en) Inhibitors of beta-secretase
EA201591634A1 (en) DIHYDROPYRIDOPYRIMIDINE COMPOUNDS
ECSP099216A (en) NEW DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR112015018509A2 (en) imidazo pyridine compounds
AR090112A1 (en) EFFECTIVE SULFINYLAMINOBENZAMIDS AS HERBICIDES
NI201000134A (en) NEW DIHYDROINDOLONE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AR097894A1 (en) CDK8 THERAPEUTIC INHIBITORS OR USE OF THE SAME
BR112017019805A2 (en) Morphinan derivative
ECSP10010315A (en) DERIVATIVES OF 19-NOR-STEROID THAT HAS A GROUP 15, 16-METHYLENE AND A RING OF 17.17-SATURATED ESPIROLACTONE, ITS USE AND DRUGS THAT UNDERSTAND THEM
AR109467A1 (en) COMPOUNDS, PROCEDURE FOR OBTAINING COMPOUNDS, PHARMACEUTICAL COMPOSITION, USE OF COMPOUNDS AND METHOD OF TREATMENT OF PSYCHIATRIC DISORDERS AND / OR SLEEP DISORDERS
AR115020A1 (en) NITROGENATED HETEROCYCLIC COMPOUND AND ITS USE AS ANTAGONIST OF THE NMDA RECEPTOR
AR066971A1 (en) DERIVED FROM 17BETA-CIANO-19-NOR-ANDROST-4-ENO- ITS USE AND MEDICATION THAT CONTAINS IT
CU20100137A7 (en) DERIVATIVES OF 19-NOR-STEROID THAT HAS A GROUP 15, 16-METHYLENE AND A RING OF 17, 17-SATURATED ESPIROLACTONE, ITS USE AND MEDICINES THAT UNDERSTAND
BR112015023280A2 (en) dihydroquinolin-2-one derivatives for use as aldosterone synthase inhibitors